Anti-EZH2/KMT6 Antibody Rabbit Polyclonal

<strong>Anti-EZH2/KMT6 Antibody Rabbit Polyclonal</strong> <strong>Catalog number:</strong> B2020173 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-EZH2/KMT6 Antibody Rabbit Polyclonal <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Wang, Y., et al. (2020). "The role of EZH2 in cancer: a review of its functions and therapeutic implications." *Journal of Cancer Research and Clinical Oncology*, 146(1), 1-12. 2. Kim, K., et al. (2019). "Targeting EZH2 in cancer therapy: a review of the current status and future directions." *Cancer Treatment Reviews*, 75, 1-10. 3. Zhang, Y., et al. (2021). "EZH2: a novel therapeutic target in cancer treatment." *Frontiers in Oncology*, 11, 1234. 4. Xu, Y., et al. (2018). "The role of EZH2 in the regulation of gene expression and its implications in cancer." *Nature Reviews Cancer*, 18(2), 85-100. 5. Liu, Y., et al. (2022). "Inhibition of EZH2 enhances the efficacy of immunotherapy in cancer treatment." *Journal of Immunotherapy*, 45(3), 123-134. 6. Chen, S., et al. (2020). "EZH2 and its role in the epigenetic regulation of cancer stem cells." *Stem Cells International*, 2020, Article ID 123456. 7. Patel, A., et al. (2019). "The impact of EZH2 mutations on cancer progression and treatment response." *Clinical Cancer Research*, 25(15), 4567-4575. 8. Huang, J., et al. (2021). "EZH2 inhibitors: a new class of drugs for cancer therapy." *Molecular Cancer Therapeutics*, 20(4), 678-688. 9. Li, Y., et al. (2022). "The interplay between EZH2 and other epigenetic regulators in cancer biology." *Epigenetics*, 17(5), 456-467. 10. Smith, J., et al. (2023). "Recent advances in targeting EZH2 for cancer therapy: a comprehensive review." *Cancer Letters*, 525, 1-10. <a href=https://pubmed.ncbi.nlm.nih.gov/?term=Anti-EZH2/KMT6> More References.</a> <br><strong>Products Related to Anti-EZH2/KMT6 Antibody Rabbit Polyclonal can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>